News
STAT+: Sanofi, Regeneron expand partnership after Dupixent success
Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.
More in Health
- Charity threatens legal action over two-year NHS wait for ADHD and autism assessments The Guardian — Society
- The children dying in India's remote tribal heartland BBC News — Health
- Medical Records Firm Uses AI Tool to Expose Flaws that Threaten Patient Privacy The New York Times — Health
- After failed execution, health workers say Tennessee's method flouts medical ethics NPR — Health
- WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental health World Health Organization